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Abstract
Objective: To establish the ability of contrast enhanced motion corrected Cadence Pulse
Sequencing (CPS) to detect changes in renal blood flow induced by vasoactive substances in rats.
Methods: Ultrasound contrast media was administered as a constant rate infusion into a phantom
at a known rate and CPS data acquired. Rats were anesthetized and pre-drug CPS estimates of
replenishment rate were made for the right kidney. Real-time motion correction was applied and
parametric images were generated from the CPS data. Group 1 rats (n=7) were administered a
vasodilator and Group 2 rats (n=3) were given a vasoconstrictor. CPS imaging of the kidney was
repeated following ample time for drug effects to occur.
Results: Contrast CPS accurately estimated flow velocity in the phantom model. In addition, CPS
defined statistically significant differences between pre and post drug blood flow in the renal medulla
(vasodilator, p<0.01; vasoconstrictor, p<0.0001) and cortex (vasoconstrictor, p<0.0001).
Conclusions: We conclude that motion corrected CPS ultrasound provides real time quantification
of renal blood flow alterations and may prove useful for the assessment of blood flow in transplanted
kidneys.
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Introduction
Non-invasive imaging methods such as MR angiography 1, CT angiography 2 and Doppler
ultrasound 3 are used to assess renal vascular health in order to guide clinical judgements
regarding management of people with kidney disease. Color and spectral Doppler sonography
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are frequently used methods by which to assess renal perfusion non-invasively and have proven
particularly useful for the assessment of functional and compromised renal transplants 4, 5.
Transplant perfusion is assessed using measures of resistive and perfusion index. However,
these measures are only useful for the assessment of large arteries and are insensitive to
alterations in vascular perfusion at the microvascular level 6. With the addition of microbubble
contrast agents, ultrasound becomes sensitive to capillary-sized vessels and very low flow rates
while maintaining the ability to detect morphological information from traditional B-mode
imaging. Ultrasound contrast agents are composed of high molecular weight gases
encapsulated in an albumin, polymer or lipid shell7. These agents are strictly intravascular thus
eliminating the need to differentiate intra from extravascular contrast agent. A variety of
contrast specific pulse sequences designed to enhance non-linear echoes that are specifically
produced by microbubble contrast agents have been developed and employed for the
interrogation of regions of myocardial infarction, tumor microvasculature, and responses to
therapy in both clinical and research settings6, 8-11.
Another feature of ultrasound contrast agents is that they are destroyed when subjected to
ultrasound of appropriate frequency and sufficient pressure 7. A destructive pulse of ultrasound
can be used to fragment the contrast agent within the region being imaged. Lower pressure,
higher frequency, non-destructive pulses can be used to visualize the replenishment of
intravascular contrast agent into the imaging region. The echo amplitude can be measured as
the contrast agent re-fills the region and the rate of return can be estimated. Such a destruction-
replenishment method was described as early as 1998, where Wei et al proposed the method
for the assessment of blood flow velocity in the myocardium11. Continued research has been
performed in the assessment of replenishment after acute myocardial infarction11 and in
abdominal organs such as kidney and liver 6, 12.
Cadence Contrast pulse sequencing (CPS) is a non-linear ultrasound contrast imaging
technique which uses a multipulse transmit sequence with precise changes in interpulse
amplitude and phase that when received and combined allow for the rejection of linear (tissue)
echoes while non-linear contrast echoes are retained 13. The effect is of a real-time positive
contrast angiogram. This technique has been used for the qualitative assessment of regional
brain and solid organ infarction, liver and renal masses, and response to radiofrequency ablation
of tumors in people 14-18.
As with all ultrasound contrast imaging sequences, the use of CPS for the quantification of
vascular parameters is compromised by tissue motion. Speckle tracking algorithms are methods
for directly tracking the backscattered echoes produced by ultrasonic scatterers in blood or
tissue 19. Speckle patterns remain relatively constant as the tissue moves so that they can be
tracked by pattern matching techniques. Several different speckle tracking techniques have
been described however many come at a high computational cost directly related to the size of
the search region and tracking kernel20-22. For real-time imaging, the sum absolute difference
(SAD) method has been suggested because it is computationally simpler than other algorithms
while still performing well in quantitative phantom experiments of motion tracking23.
The purpose of this study was to test the ability of motion corrected CPS combined with a
destruction-replenishment scheme to quantify responses of the renal vasculature to vasoactive
substances in normal rats. This native kidney model was chosen because this is a proof of
concept study and, should changes in blood flow not be quantifiable in normal kidneys, the
system would be unlikely to detect changes in diseased or transplanted kidneys were flow
alterations may be subtle. SAD motion correction with destruction-replenishment CPS is a
novel combination of features never before described for the real-time quantification of renal
blood flow velocity. We hypothesized that this technique would prove to be sensitive and
repeatable for the quantification of renal blood flow alteration. The goal of this pilot project is
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to determine if this new system can provide real-time quantification of changes in renal blood
flow with outstanding repeatability so as to ultimately allow for the detection of cortical
hypoperfusion in compromised kidneys. We anticipate this system will be useful initially as a
research tool in rodents intended to further the understanding of renal blood flow in native and
transplanted kidneys with potential application in clinical patients in the future.
Materials and Methods
In Vitro Phantom Study
30 silicone tubes (Dow Corning, Midland, MI) were bound together to form a bundle so as to
mimic a vascular network. Both ends of the bundle were sealed into two small cylinder-shaped
chambers, which hold 0.35mL of liquid. Each tube had an inner diameter of 0.635 mm and
outer diameter of 1.1938 mm. Assuming a volume within the phantom tubes of 0.6 mL with a
cross-sectional area of 6mm2 and a syringe pump flow rate of 24*10−3 mL/s, we estimated a
linear velocity of ∼4 mm/s in the phantom tubes. Acoustic coupling gel (Aquasonic, Parker
Labs, Fairfield, N.J.) was used to couple the transducer to the phantom. The phantom was
placed on top of an ultrasound gel pad (Aquasonic, Parker Labs, Fairfield, N.J.). Contrast agents
were produced in our laboratory as described previously 24; the agents were designed to have
similar properties and a similar formulation to lipid-shelled agents used in the in vivo studies.
The contrast agent was continuously injected at a speed of 4 mm/sec, which ranged within the
biological flow rate set by a syringe pump (Harvard Apparatus, Holliston, MA). The ultrasound
machine parameters were set to optimize the CPS image quality (7 MHz; CPS gain = −20; 0.28
MI) during application of the destruction-replenishment technique. The position of the
transducer and the phantom is shown in Figure 1, with an azimuthal window of 14 mm.
Animals
Ten adult, male outbred, albino Sprague-Dawley® rats (Harlan Sprague Dawley Inc.,
Indianapolis, IN) were imaged during these studies. Rats were approximately 450-500g each.
Animal use protocols were approved by the Institutional Animal Care and Use Committee of
the University of California, Davis. All animals were housed in a standard animal facility, fed
a standard diet and given free access to food and water.
In Vivo Ultrasound Imaging Protocol
Ultrasound was performed using an Acuson Sequoia 512® system (Siemens Medical Solutions
USA, Inc., Ultrasound Division, Issaquah, WA) with a 15L8 linear array transducer. Animals
were anesthetized initially by placing each rat into an induction chamber and introducing 5%
aerosolized isoflurane in oxygen. Once anesthetized, the rat was removed from the chamber
and anesthesia was maintained by titrating isoflurane/02 using a nose mask. Prior to imaging,
the abdomen of each rat was shaved and further depiliated using Nair (Church & Dwight, Co.
Princeton, N.J.). Acoustic coupling gel (Aquasonic, Parker Labs, Fairfield, N.J.) was used to
couple the transducer to the skin surface. A sagittal image of the right kidney was obtained and
the transducer was mechanically fixed in position with an articulated arm. Definity (Bristol-
Myers Squibb, N. Billerica, MA) was activated by shaking according to the manufacturer's
instructions and diluted with 100 μL to 600 μL sterile saline in a 3 cc syringe immediately
before injection. Contrast agent was injected at 60 microliters/minute using a syringe pump
(Harvard Apparatus, Holliston, MA) through a 24 gauge tail vein catheter with injection port.
The continuous-rate injection was initiated 2 minutes prior to each imaging sequence to allow
circulating contrast concentration to stabilize. Parametric maps of replenishment were acquired
in real-time using Siemens Cadence™ contrast pulse sequencing (CPS) motion sensing probe
(MSP) pulse sequencing and processing, which involved transmission of a low frequency,
high-MI destructive pulse (7 MHz, 1.9 MI) which cleared the sample volume of contrast agent,
followed by a series of lower MI (7 MHz, 0.28 MI) pulses to image contrast as the kidney was
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reperfused. Automated MSP processing involved frame alignment using a real-time sum of
absolute difference based search based on the derived B-mode information, and then further
mapping of the colors of each pixel according to time to reach an intensity threshold set to 20%
of full scale. The colormap was a non-linear map designed to provide high sensitivity to small
differences in fast blood flow (fast arrival time), and lower sensitivity to changes in slow blood
flow (slow arrival time). The arrival time was determined on a pixel by pixel basis by assigning
each pixel a time value based on the elapsed time from the destruction event to the time that
the CPS signal reaches 20% of the maximum value. The arrival time for pixels that had achieved
the required signal level was then color-coded. Final images were recorded and saved for
further offline processing to quantify replenishment in designated regions. The gain setting
(CPS gain= 10) and depth (4 cm) were left constant in all studies.
Drug administration
Imaging data was acquired prior to vasoactive drug administration. Changes in renal blood
flow were subsequently mediated by administration of either the vasodilator hydralazine (n=7
rats) or the vasoconstrictor dopamine (Dopamine, Abbott Laboratories, Chicago, IL) (n=3 rats).
Hydralazine (5mg/kg) was administered as a bolus. Imaging was performed 30 minutes after
Hydralazine administration to allow for the drug to take effect. Only a single value was recorded
for each animal pre and post drug. Dopamine was administered at a constant rate infusion (10
μg/kg/min) via a second tail vein catheter over 12 minutes. Imaging was repeated during
Dopamine administration but after a 10-minute delay to allow for the drug to take effect. At
least 4 image acquisitions were performed prior to and after Dopamine administration. This
was specifically done so as to assess parameter repeatability. Once imaging procedures were
completed, rats were recovered from anesthesia and returned to the vivarium.
Post-Processing
Captured images were post-processed in MATLAB (Mathworks, Natick, MA). Regions of
interest (ROIs) were manually selected around the entire cortex, the cortex and medulla of the
kidney. Mean time to 20% (TT20%) maximum enhancement for the entire kidney, the medulla,
and the cortex were derived from the time value of each pixel within the ROIs based on the
colormap. The percent change in TT20% was calculated between the pre and post drug values
for the entire kidney, the cortex and the medulla.
Statistical Analysis
Statistical analysis was performed using commercially available software (Excel, Microsoft
Corporation, Redmond, WA). Mean (± standard deviation) values were calculated for each
animal in the Dopamine group so as to assess the repeatability of parameter estimation within
a given individual. Then the mean (± standard deviation) values from all animals in each group
were pooled and a Student t-test was used to evaluate for significant differences between the
pre and post drug TT20% values for the entire kidney, the cortex and the medulla. A p-value
< 0.05 was considered significant.
Results
Phantom Study
Based on the color map we designed for the destruction-replenishment technique, the light
yellow color indicated fast arriving flow; red and pink colors indicated slow arriving flow
(Figure 2). The distribution of the color in the perfused region showed the flow direction and
agrees with the flow direction and flow rate set in the experiment. The arrival times in each
ROI are plotted in Figure 2, which vary across the image from less than 1 second to 3.5 seconds.
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This corresponds with an estimated linear velocity of 4 mm/s which equals the true velocity
set for the syringe pump (R2=0.91).
Drug administration studies
The mean (± SD) TT20% for the entire kidney prior to vasoactive drug administration in the
Dopamine group (n=3) was 0.72 (± 0.04) s. The mean TT20% for the renal cortex and medulla
prior to vasoactive drug administration in the Dopamine group was 0.47 (± 0.02) s and 1.06
(± 0.07) s, respectively. The mean TT20% for the entire kidney during Dopamine
administration (n=3) was 0.63 (± 0.05) s, which represented a 12.5 % decrease in replenishment
time and was statistically significantly different from the pre-Dopamine values (p<<<0.0001).
The mean TT20% for the renal cortex and medulla during Dopamine administration was 0.43
(± 0.01) s (8.5% decrease) and 0.88 (± 0.12) s (17% decrease), respectively. Both parameters
were significantly different from the pre-Dopamine values (p<<<0.0001 for both). Values for
individual rats are shown in Figure 3 (a-c). Note the small standard error bars representing the
variability in the 4 different measurements acquired in each individual rat implying good
repeatability. Parametric images show differences in renal replenishment times during
Dopamine administration (Figure 3 d,e).
The mean (± SD) TT20% for the entire kidney prior to vasoactive drug administration in the
Hydralazine group (n=7) was 0.64 (± 0.17) s. The mean TT20% for the renal cortex and medulla
prior to vasoactive drug administration in the Hydralazine group was 0.46 (± 0.03) s and 0.95
(± 0.28) s, respectively. The mean TT20% for the entire kidney after Hydralazine
administration (n=7) was 0.83 (± 0.24) s, which represented a 29.7% increase in replenishment
time and was statistically significantly different from the pre-Hydralazine values (p=0.02). The
mean TT20% for the renal cortex and medulla during Hydralazine administration was 0.54 (±
0.10) s (17.4% increase) and 1.32 (± 0.45) s (38.9% increase), respectively. Significant
differences were found in comparison to the pre-Hydralazine medullary values (p=0.01) but
not the cortical values (p=0.10). Values for individual rats are shown in Figure 4 (a-c).
Parametric images show differences in renal replenishment times during Hydralazine
administration (Figure 4 d,e).
Comments
The results of this study indicate that motion corrected CPS ultrasound combined with a
destruction-replenishment scheme is capable of estimating true velocity in a phantom model.
When estimating replenishment time, this system accurately depicted fast replenishment in the
region closest to the syringe pump input and depicted slower replenishment in the further
regions. Moreover, good correlation was found between true velocity and parametric estimates
in vitro. This system also appears capable of quantifying significant changes in renal cortical
and medullary blood flow velocities in vivo induced by the systemic administration of
vasoconstrictive or vasodilatory substances. The kidney is highly regulated so that systemic
changes in vascular tone and blood pressure will result in modifications of renal blood flow
with the end goal being maintenance of glomerular filtration 25. Thus, if the systemic and renal
vasculature is constricted, flow velocity (replenishment) must increase so as to maintain overall
blood flow. Likewise, if the systemic and renal vasculature is dilated, flow velocity will
decrease. Dopamine is known to increase renal blood flow related to increased flow velocity
in constricted vessels. Hydralazine is known to decrease renal blood flow related to a decrease
in flow velocity in dilated vessels.
Our results show that this system was capable of identifying such changes. In fact, a similar
study using contrast enhanced MRI to evaluate the effect of vasomodulatory drugs on blood
flow in a variety of tissues in rats was less sensitive to alterations in renal blood flow velocity
with the administration of hydralazine although overall renal blood flow decreased by 26%
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26. The administration of a different vasoconstrictor (histamine) resulted in a 68% increase in
renal blood flow velocity in that study which may be a reflection of the difference in the 2
drugs.
Previous authors have used contrast ultrasound techniques to evaluate blood flow in normal
and diseased native kidneys 27 but predominantly in functional and compromised transplanted
kidneys28-32. We believe this ultrasound imaging system is novel in several ways potentially
providing more reliable data. First, the SAD motion correction algorithm reduces the effect of
tissue and respiratory motion upon parameter generation. Motion correction allows frames over
a long period of time to be combined using a maximum intensity projection or to compute
spatially varying contrast agent arrival time. Tissue motion is detrimental to image quality and
severely limits the accuracy of ROI calculations. Particularly in the cranial abdomen,
respiratory motion can be quite dramatic such that an ROI may contain cortical tissue at
inspiration and medullary tissue at expiration. Given the differences between cortical and
medullary flow, this would dramatically influence TT20% or other blood flow measurements.
It is important to note that this motion correction algorithm accounts for in-plane motion but
not for out-of-plane motion. Based on the typical pattern of rodent respiration, in-plane motion
in the cranial and caudal directions predominates. However, the effect of out-of-plane motion
on parameter estimation is not known and must be addressed in future studies.
Second is the introduction of an automated destruction-replenishment scheme in combination
with CPS. Parametric images were generated during the imaging session, which allowed clear
differentiation between cortical and medullary tissue within the kidney. This streamlined the
qualitative assessment of the imaging data and minimized the post-processing time. A non-
linear colormap was chosen for data acquisition in the kidney because we expected rapid
replenishment to dominate. By distributing the colormap in a way that amplified small
differences between rapidly replenished areas, this system was capable of detecting more subtle
flow differences and alterations.
We chose to evaluate the TT20% parameter as a robust parameter that can be independent of
attenuation. Since this is a relative measure of the change in the echo intensity over the
transmitted imaging pulse train, it may overcome some limitations of previous efforts to
quantify microvascular flow with ultrasound. More specifically, this parameter is not likely to
be affected by slight differences in bubble concentration nor does it rely on the questionable
assumption that signal intensity is directly related to bubble (and therefore blood) volume.
Indeed, as shown by the low standard deviation between repeated measurements within a given
rat, it appears that this parameter is highly reproducible if the transducer is not moved.
It is important to note that it was not the intent of this study to establish a range of values
representative of normal renal blood flow. In fact, when looking at the pre-drug data, there was
substantial inter-individual variation of the TT20% values. This may indicate true inter-
individual variation or represent noise within the system when applied in vivo. Although little
noise was detected during the phantom study, this question could only be answered by
comparison of the TT20% value to an in vivo gold standard. While it is possible that a range
of normal TT20% replenishment values can be established, the change in this parameter over
time within a given individual may ultimately be more useful and interesting.
A limitation and concern not addressed in this study involves the relative difficulty of exactly
reproducing the same imaging plane during serial studies so that variations within the kidney
itself are accounted for. As such, one must be certain that an adequate representation of regional
tissue blood flow is sampled in order to eliminate the possibility that the choice of imaging
plane is influencing the outcome during sequential examinations. One possible way to
overcome this limitation is by averaging quantitative values over several imaging planes. This
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may provide a more accurate regional estimate of blood flow and eliminate the need to exactly
reproduce the imaging plane used in previous examinations. Additional studies will be
necessary to determine if this will sufficiently address the limitation of imaging plane
reproducibility. Alternatively, 2D arrays are currently in various stages of development and
application. The combination of real time 3D imaging with destruction-replenishment CPS
would allow for the global assessment of tissue or organ blood flow from which quantitative
data could be extracted from, for example, the entire renal medulla. It is likely that this will
ultimately be necessary prior to advancement into clinical application in order to reduce the
error introduced by the inability to reproduce the same imaging plane.
Another limitation of this study is that blood pressure changes were not recorded in these
animals. Non-invasive, accurate blood pressure measurement is notoriously difficult in rats.
Blood pressure and heart rate monitoring may be useful during future studies using this
technique to ensure that the drugs are taking the expected effect and as a gauge for the
anticipated effect on renal blood flow.
Conclusions
Motion corrected destruction-replenishment CPS ultrasound appears to be a non-invasive
method for quantifying renal blood flow velocity. Quantitative parameters derived from motion
corrected ROI analysis appear to be robust when the imaging plane is not altered while the
acquisition of multiple imaging planes or the implementation of a 2D array transducer may be
necessary to apply this technique in serial tissue assessment. Although still developmental, this
technique shows promise as a pre-clinical method for monitoring changes in renal blood flow
velocity over time. Additional studies will be necessary to further define the role of motion
corrected CPS destruction-replenishment ultrasound for the assessment of renal disease and in
complicated renal transplants.
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a. The tube phantom is shown. b.The phantom is attached to a syringe pump for injection of
contrast media at a controlled rate. The ultrasound transducer is coupled to the phantom using
gel and fixed in place with a mechanical arm. c. A schematic is depicted showing the ultrasound
transducer and the flow direction in the phantom tubes.
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The time to 20% replenishment is shown for the tube phantom imaged at a constant infusion
rate of 4 mm/sec. The top parametric image shows the replenishment times and the regions of
interest drawn over the tubes. When arrival time is plotted against the region of interest, it
becomes clear that arrival times are longer for regions that are further from the input of the
phantom. This shows that the system is measuring shorter and longer replenishment times
accurately for a known flow velocity.
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a. The time to 20% maximum replenishment (TT 20%) is shown for a region of interest (ROI)
drawn around the entire kidney prior to and after administration of Dopamine. Note that all 3
rats showed a decrease in replenishment times indicating more rapid refill after Dopamine.
Values shown represent a mean of 4 measurements taken at each time point in each rat with
standard error bars demonstrating measurement repeatability. b. The TT 20% is shown for an
ROI drawn in the renal cortex prior to and after administration of Dopamine. Note that all 3
rats showed a decrease in replenishment times indicating more rapid refill after Dopamine.
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Values shown represent a mean of 4 measurements taken at each time point in each rat with
standard error bars demonstrating measurement repeatability. c. The TT 20% is shown for an
ROI drawn in the renal medulla prior to and after administration of Dopamine. Note that all 3
rats showed a decrease in replenishment times indicating more rapid refill after Dopamine.
Values shown represent a mean of 4 measurements taken at each time point in each rat with
standard error bars demonstrating measurement repeatability. d.A parametric image of the right
kidney is shown prior to vasoactive drug administration. The colorbar shows time to 20%
replenishment with the most rapid replenishment represented in yellow and the slowest
replenishment represented in red. Notice that the colormap is non-linear with more color
options present in the shortest replenishment time range. e. The same kidney is shown after
administration of the vasoconstricting drug Dopamine. Cortical replenishment is now almost
completely represented by yellow and medullary replenishment tends more toward green and
blue (more rapid replenishment) in comparison to a.
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a. The time to 20% maximum replenishment (TT 20%) is shown for a region of interest (ROI)
drawn around the entire kidney prior to and after administration of Hydralazine. Note that all
7 rats showed an increase in replenishment times indicating slower refill after Hydralazine.
b. The TT 20% is shown for an ROI drawn in the renal cortex prior to and after administration
of Hydralazine. Note that all 7 rats showed an increase in replenishment times indicating slower
refill after Hydralazine. c. The TT 20% is shown for an ROI drawn in the renal medulla prior
to and after administration of Hydralazine. Note that all 7 rats showed an increase in
replenishment times indicating slower refill after Hydralazine. d. A parametric image of the
right kidney is shown prior to vasoactive drug administration. The colorbar shows time to 20%
replenishment with the most rapid replenishment represented in yellow and the slowest
replenishment represented in red. Notice that the colormap is non-linear with more color
options present in the shortest replenishment time range. e. The same kidney is shown after
administration of the vasodilatory drug Hydralazine. Cortical replenishment is relatively
similar while medullary replenishment tends more dark blue and purple (slower replenishment)
in comparison to a.
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